Niall O'Donnell Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 6 days, 22 hours ago

Niall O'Donnell has an estimated net worth of at least $85.6 million*, as of July 2, 2025. They own 1.6 million shares of MIRM stock. They have sold 300,000 shares of MIRM stock since 2021, for an estimated $6.0 million.

Niall O'Donnell $MIRM SEC Form 4 Insider Trading

Niall O'Donnell has filed a total of 3 insider trades in $MIRM since 2021. Their most recent trade was a sale of 174,121 shares, made on Nov 11, 2022. Their largest trade was a sale of 174,121 shares, made on Nov 11, 2022. We estimate that they now own 1.6 million shares of $MIRM, worth an estimated $79.6 million.

Insider Trading at $MIRM

There have been a total of 98 insider trades reported at $MIRM since 2021, with 189,177 shares purchased and 850,046 shares sold. The most active insider traders in $MIRM stock have been Jolanda Howe, Peter Radovich, and Christopher Peetz. The most recent trade was a sale of 564 shares reported by Jolanda Howe (SVP, GLOBAL CONTROLLER), made on Jul 02, 2025.

History of Insider Stock Trades by Niall O'Donnell

Company Ticker	Purchase / Sale	Shares	Date	Disclosed (EST)
SPRB	Purchase	630,400	Feb 16, 2023	May 16, 2023, 4:08 p.m.
RPHM	Purchase	125,000	May 08, 2023	May 10, 2023, 5:47 p.m.
MIRM	Sale	174,121	Nov 11, 2022	Nov. 15, 2022, 9:02 p.m.
MIRM	Sale	32,109	Nov 14, 2022	Nov. 15, 2022, 9:02 p.m.
MIRM	Sale	93,770	Nov 15, 2022	Nov. 15, 2022, 9:02 p.m.

$MIRM Executives and Stock Owners with Insider Trades

Jolanda Howe, SVP, GLOBAL CONTROLLER
Peter Radovich, PRESIDENT AND COO
Christopher Peetz, CHIEF EXECUTIVE OFFICER
Lara Longpre, CHIEF DEVELOPMENT OFFICER
Ian Clements, Chief Financial Officer
Christopher Peetz, President and CEO
Pamela Vig, CHIEF SCIENTIFIC OFFICER
Jolanda Howe, SVP, Global Controller
Eric Bjerkholt, CHIEF FINANCIAL OFFICER
Lara Longpre, Chief Development Officer
Peter Radovich, Chief Operating Officer
Eric Bjerkholt, Chief Financial Officer
Edwin Jonathan Tucker, Chief Medical Officer
Joanne Quan, CHIEF MEDICAL OFFICER
Christopher Peetz, PRESIDENT AND CEO
Pamela Vig, Chief Scientific Officer
Pamela Vig, HEAD OF RESEARCH & DEVELOPMENT
Pamela Vig, Head of Research & Development
Peter Radovich, CHIEF OPERATING OFFICER

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.